Bis-naphthalimides: a new class of antitumor agents

Anticancer Drug Des. 1993 Aug;8(4):257-68.

Abstract

A series of bis-intercalators bearing the 1,8-naphthalimide chromophore has been synthesized and in vitro activities determined. Most compounds have higher activities in HT-29 than the leader compounds Mitonafide and Amonafide. One of them (22) was selected for in vivo studies and presents an interesting activity in MX-1 and OVCAR models. (22) also acts as antitopoisomerase II.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine
  • Animals
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Humans
  • Imides / chemical synthesis*
  • Imides / chemistry
  • Imides / pharmacology
  • Intercalating Agents / chemical synthesis*
  • Intercalating Agents / pharmacology
  • Isoquinolines / chemical synthesis*
  • Isoquinolines / chemistry
  • Isoquinolines / pharmacology
  • Mice
  • Naphthalenes / chemical synthesis*
  • Naphthalenes / chemistry
  • Naphthalenes / pharmacology
  • Naphthalimides
  • Neoplasms, Experimental / drug therapy
  • Organophosphonates
  • Structure-Activity Relationship
  • Tumor Cells, Cultured / drug effects

Substances

  • Antineoplastic Agents
  • Imides
  • Intercalating Agents
  • Isoquinolines
  • Naphthalenes
  • Naphthalimides
  • Organophosphonates
  • mitonafide
  • amonafide
  • Adenine